Drug development faces challenges like slow timelines, unclear data ownership, and difficulty translating biomarkers into clinical practice. At GSL, we turn these challenges into opportunities with precision-driven solutions that accelerate success.
Rapid turnaround of high- quality data ensures you get actionable insights when you need them most.
Harnessing AI, mass spectrometry, and decades of expertise to assay thousands of dynamic, non-genetic biomarkers.
Complete access and ownership of your data. No hidden processes, no barriers.
From discovery to validation and clinical implementation, supported by our accredited labs.
GSL leads the way in lipid testing services for both industry partners and the NHS. With over 30 years of expertise, our lipid panels deliver precise analysis for diagnosing and monitoring Lysosomal Storage Disorders, as well as cardiovascular and neurological conditions, providing accurate, reliable results you can trust.
We specialize in developing multiplexed, targeted proteomic panels for high- throughput biomarker validation. Collaborating with leading academic partners, our team advances Omics into clinical practice through cutting-edge proteomics technology, transforming biomarkers into actionable insights that can revolutionize healthcare.
We provide comprehensive, customizable metabolite analysis services, including specialized assays for rare diseases and bespoke solutions tailored to your needs. Our experienced team is committed to delivering accurate, high-quality results that drive research forward.